Cargando…
A Peptide Vaccine Design Targeting KIT Mutations in Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a leading blood cancer subtype that can be caused by 27 gene mutations. Previous studies have explored potential vaccine and drug treatments against AML, but many were proven immunologically insignificant. Here, we targeted this issue and applied various clinical filt...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383192/ https://www.ncbi.nlm.nih.gov/pubmed/37513844 http://dx.doi.org/10.3390/ph16070932 |